TED website is eForms ready from today 02/11/2022. Search changed: please adapt your predefined expert queries. Discover the changes in the site news and in the updated Help Pages
EU solidarity with Ukraine
Prozorro+: Ukrainian public procurement platform
United Kingdom-Belfast: Research services
Section I: Contracting authority
Section II: Object
QUB/1850/19 Contract for Clinical Research Organisation
Queen's University Belfast seeks to appoint a Clinical Research Organisation (CRO) to provide services in respect of conducting a multinational Phase II study in non-cystic fibrosis BE patients, sponsored by Novartis, across Europe. The trial will be jointly funded by Novartis and the EU Innovative Medicines Initiative (IMI) through the iABC consortium. IMI is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients (http://www.imi.europa.eu/). Access to tender documentation is restricted to those companies who download, complete and submit a CDA to Queen's.
The CRO must have the capability to manage a study across multiple EU countries.
Queen's University Belfast seeks to appoint a Clinical Research Organisation (CRO) to provide services in respect of conducting a multinational Phase II study, sponsored by Novartis, across Europe.
This contract includes the option to extend by up to a further 2 years.
Section III: Legal, economic, financial and technical information
The CRO must be capable of conducting a randomised Phase II clinical study across Europe. The CRO will not be permitted to sub-contract core services under the funding guidelines and therefore must have the capacity to provide the full suite of services outlined in the specification.
Section IV: Procedure
Section VI: Complementary information
Economic operators seeking to obtain tender documentation, must first download, complete and submit a confidential disclosure agreement. Tender documents will not be issued until a completed CDA has been received.
This authority will incorporate a standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into. The Public Contract Regulations 2015 (SI 2015/102) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland).